Monday, November 21, 2016

GlaxoSmithKline seeks U.S. approval for triple lung drug

LONDON, Nov 21 (Reuters) - GlaxoSmithKline said on

Monday it had filed its new three-in-one inhaled lung drug for

U.S. approval, putting it on track to reach the market ahead of

rivals in 2017,...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)